510(k) Report

510(k) · Cleared

Recalled · Class II · 2024

Dimension Vista Tbil Flex Reagent Cartridge, and Dimension Vista Tbil/Dbil Calibrator; Models K1167, KC212

K061719510(k) TraditionalCleared Aug 25, 200667-day reviewClass II21 CFR 862.1110Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dade Behring, Inc. · CIG Diazo Colorimetry, Bilirubin

Cleared on Aug 25, 2006 as substantially equivalent to K861700 (E.I. Dupont DE Nemours & Co., Inc., 1986) after a 67-day review. Its family tree reaches back 1 generation to 1986. 1 later device descends from it. It has been recalled 2 times.

Decided
Aug 25, 2006
Review
67 days
Class
Class II
Product code
CIG
Recalls
2
Predicates
1

Its longest line of descent runs back 1 generation to K861700 (1986). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2007: 1 descendant clearedK861700 · Dimension (TM) Clinical Chemistry System · E.I. Dupont DE Nemours & Co., Inc. · 1986 · recalled1990200020102020
Descendants, by generation 1 generation forward: 1 descendant K861700 · Dimension (TM) Clinical Chemistry System · E.I. Dupont DE Nemours & Co., Inc. · 1986 · recalled0
  1. Root · 1 generation backK861700 Dimension (TM) Clinical Chemistry SystemE.I. Dupont DE Nemours & Co., Inc. · 1986 · Recalled
  2. This deviceK061719 Dimension Vista Tbil Flex Reagent Cartridge, and Dimension Vista…Dade Behring, Inc. · 2006
  3. Descendant · cites it directly · 0 of its ownK072717 Dimension Vista System Bilirubin Calibrator, Model KC210Dade Behring, Inc. · 2007

Most influential descendants

Showing 1 of 1 · See all
  • K072717Dimension Vista System Bilirubin Calibrator, Model KC210Dade Behring, Inc. · 2007 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K861700Dimension (TM) Clinical Chemistry SystemE.I. Dupont DE Nemours & Co., Inc.19862
0 (this device)K061719Dimension Vista Tbil Flex Reagent Cartridge, and Dimension Vista Tbil/Dbil…Dade Behring, Inc.2006—
+1K072717Dimension Vista System Bilirubin Calibrator, Model KC210Dade Behring, Inc.2007—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
FIG. 1 — Lineage of K061719, 1986–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CIG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CIG device

  1. #1 K251998 Atellica CH Diazo Total Bilirubin (D_TBil)score 11.8 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K861700Dimension (TM) Clinical Chemistry System
Summary page 1
…Bilirubin Calibrator Predicate Device: Dade Behring Dimension® TBIL Flex® reagent cartridge and TBIL/DBIL Calibrator (k861700) Device Description: TBIL Flex®& reagent cartridge Diazotized sulfanilic acid is formed by combining sodium nitrite a…
E.I. Dupont DE Nemours & Co., Inc.19862

Also cleared against K861700: 5 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K072717Dimension Vista System Bilirubin Calibrator, Model KC210Dade Behring, Inc.20070

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 30, 2024Class IIZ-3065-2024Software Manufacturing/Software DeploymentDuring manufacturing, the last three tests from the 160 test flex of lot 23206BA (wells 8 or 10) were processed on the Dimension Vista platform. There was an issue with the filling line which led to some wells to underfill in lot 23206BA.…
Feb 13, 2020Class IIZ-1541-2020Under Investigation by firmBilirubin assays may exhibit a positive bias with patients on eltrombopag therapy

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K072717 (Dade Behring, Inc., 2007) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K861700.

How does its category compare?

All CIG devices

CIG Diazo Colorimetry, Bilirubin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CIG

2in 2023

2007: 12008: 32009: 22010: 12011: 22013: 52015: 12017: 12019: 12022: 12023: 22026 (partial year): 1
2007high 5 (2013) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CIG

64in 2013

2008: 199 days median2013: 64 days median
2007high 199 (2008) · low 64 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CIG

1in 2019

2009: 32013: 32019: 1
2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CIG

52in 2025

2007: 22008: 82009: 32010: 62011: 382012: 142013: 82014: 32015: 72016: 42017: 112018: 232019: 252020: 312021: 222022: 262023: 342024: 392025: 52
2007high 52 (2025) · low 2 (2007)2025

MAUDE reports naming product code CIG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—02
2008319908
20092—33
20101—06
20112—038
20120—014
201356438
20140—03
20151—07
20160—04
20171—011
20180—023
20191—125
20200—031
20210—022
20221—026
20232—034
20240—039
20250—052
20261—0—

What is it indicated for?

The TBIL method is an in vitro diagnostic test for the quantitative measurement of total bilirubin in human serum and plasma on the Dimension VistaTM System. Measurements of total bilirubin are used in the diagnosis and treatment of liver, hemolytic hematological and metabolic disorders, including hepatitis and gall bladder disease.

The TDBIL CAL is an in vitro diagnostic product for calibration of the Direct Bilirubin (DBIL) and Total Bilirubin (TBIL) methods on the Dimension VistaTM System.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K061719: Dimension Vista Tbil Flex Reagent Cartridge, and Dimension Vista Tbil/Dbil Calibrator; Models K1167, KC212.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K061719

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026